Free Cash Flow Build Up
Cassava Sciences Inc (SAVA)
$10.57
0.09 (+0.86%)
Year A/P | 2013 Actual | 2014 Projected | 2015 Projected | 2016 Projected | 2017 Projected | 2018 Projected | 2019 Projected | 2020 Projected | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected |
| Revenue | 41.12 | - | - | - | - | - | - | - | - | - | - | - |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA | 31.37 | - | - | - | - | - | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - | - | - | - | - | - | - |
| Tax Rate | -0.23% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.03% | -0.03% | -0.03% | -0.03% | -0.03% |
| EBIAT | - | - | - | - | - | - | - | - | - | - | - | - |
| Depreciation | - | - | - | - | - | - | - | - | - | - | - | - |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventories | - | - | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - | - | - |
| Capital Expenditure | - | -0.08 | -0.20 | -0.07 | - | - | -0.02 | - | - | - | - | - |
| UFCF | - | - | - | - | - | - | - | - | - | - | - | - |
| WACC | ||||||||||||
| PV UFCF | - | - | - | - | - | - | - | - | - | - | - | |
| SUM PV UFCF | - |